- Payment of outstanding purchase consideration to the promoter for the spin-off of the API businessb)
- Funding capital expenditure requirements
- General corporate purposes
Fresh Issue of 1,47,22,222 Shares Rs.720 = Rs.1,060.00 Crores
Offer for Sale of 63,00,000 Shares Rs.720 = Rs.453.60 Crores
Equity Shares outstanding after the Issue = 12,25,27,172 Shares
Category-wise
Break
up:
Anchor:
63,06,667
Shares
=
454.08
Crores
QIB:
42,04,444
Shares
=
302.72
Crores
NII:
31,53,333
Shares
=
227.04
Crores
RII:
73,57,778
Shares
=
529.76
Crores
(Lot
size:
20
=
3,67,889
Forms)
Total
Issue:
2,10,22,222
Shares
=
1513.60
Crores
Subscription
Required
for
1X
RII:
3,67,889
Forms
NII:
227.04
Crores
Financial Information (Basis of Valuation)
The
information
is
collated
from
the
following
documents:
1)
RHP
=
Red
Herring
Prospectus
Dated
July
19,
2021
(358
pages)
EPS
for
FY18-19
>>>
Rs.24.64
(Page
#82
of
RHP)
EPS
for
FY19-20
>>>
Rs.29.04
(Page
#82
of
RHP)
EPS
for
FY20-21
>>>
Rs.32.61
(Page
#82
of
RHP)
RoNW
for
FY18-19
>>>
99.25%
(Page
#83
of
RHP)
RoNW
for
FY19-20
>>>
77.94%
(Page
#83
of
RHP)
RoNW
for
FY20-21
>>>
46.71%
(Page
#83
of
RHP)
NAV as on March 31, 2021 was Rs.69.82 (Page #83 of RHP)
Listed
Industry
Peer
Group:
- Divis Laboratories
- Laurus Labs
- Shilpa Medicare
- Aarti Drugs
- Solara Active Pharma Sciences
Glenmark Life Sciences IPO Review
- Apply for Listing Gain and Long Term Gain
Brokerage Firm IPO Reviews
- Axis Capital: Neutral
- Choice Equity: Apply
- GEPL Capital: Apply
- Anand Rathi: Apply
- ICICI Direct: Apply
- Angel Broking: Apply
Glenmark
Life
Sciences
IPO
Date
&
Price
Band
IPO Open: |
27
July
2021 |
IPO Close: |
29
July
2021 |
IPO Size: | Approx ₹1514 Crores |
Fresh Issue: | Approx ₹1060 Crores |
Offer for Sale: |
Approx
₹454
Crores,
63,00,000
Shares |
Face Value: | ₹2 Per Equity Share |
Price Band: | ₹695 to ₹720 Per Share |
Listing on: | BSE & NSE |
Retail Portion: | 35% |
Equity: | – Shares |
Glenmark Life Sciences IPO Market Lot
Minimum Lot Size: | Minimum 20 Shares |
Minimum Amount: | ₹14,400 |
Maximum Lot Size: | Maximum 260 Shares |
Maximum Amount: | ₹187,200 |
Glenmark Life Sciences IPO Date, Time Table, Allotment & Listing
Basis of Allotment: |
27
July
2021 |
Basis of Allotment: |
29
July
2021 |
Basis of Allotment: |
03
August
2021 |
Refunds: |
04
August
2021 |
Credit to Demat Account: |
05
August
2021 |
Listing Date: |
06
August
2021 |
Glenmark Life Sciences IPO Form
How to apply the Glenmark Life Sciences IPO? You can apply Glenmark Life Sciences IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Glenmark Life Sciences IPO in the Invest section. The other option you can apply Glenmark Life Sciences IPO via IPO forms download via NSE and BSE. Check out the Glenmark Life Sciences forms – click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.
Glenmark Life Sciences Company Financial Report
₹ in Crores | |||||
Revenue | Expenses |
PAT |
|||
2018 | ₹0.25 | ₹0.26 | -₹0.43 | ||
2019 | ₹886.87 | ₹658.59 | ₹195.59 | ||
2020 | ₹1549.30 | ₹1128.24 | ₹313.10 | ||
2021
9M |
₹1418.47 | ₹1088.15 | ₹246.90 |
Company Promoters
- Glenmark Pharmaceuticals Limited
About
Glenmark
Life
Sciences
We are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, we have established strong relationships with leading global generic pharmaceutical companies that have helped us expand our product offerings and geographic reach. We work with 16 of the 20 largest generic companies globally. (Source: A Year of Surprises Shakes Up Off-Patent Industry” | Informa, 2020)
With 120 APIs in our catalogue, we are blending innovation and operational excellence to deliver on the promise of service, reliability, and consistent product quality.
Powered by our massive, world-class manufacturing and research capabilities, we supply high-quality APIs to more than 540 pharma companies in multiple countries.
Quick Links
DRHP
Draft
Prospectus
RHP
Draft
Prospectus
Glenmark
Life
Sciences
IPO
Subscription
Numbers
Glenmark Life Sciences IPO Registrar
KFin
Technologies
Private
Limited
(Formerly
known
as
Karvy
Fintech
Private
Limited)
Selenium
Tower-B
Plot
No-31
and
32,
Financial
District
Nanakramguda,
Serilingampally
Hyderabad,
Rangareddi
500032
Telangana,
India
Tel:
+91
40
6716
2222
E-mail:
[email protected]
Investor
Grievance
E-mail:
[email protected]
Website:
www.kfintech.com
Contact
Person:
M
Murali
Krishna
SEBI
Registration
No.:
INR000000221
Glenmark Life Sciences IPO Lead Managers
- Kotak Mahindra Capital Company Limited
- BofA Securities India Limited
- Goldman Sachs (India) Securities Private Limited
- DAM Capital Advisors Limited
- BOB Capital Markets Limited
- SBI Capital Markets Limited
Company Address
Glenmark
Life
Sciences
Limited
Registered
Office:
Plot
No.
170-172,
Chandramouli
Industrial
Estate,
Mohol
Bazarpeth,
Solapur
413
213,
Maharashtra
Corporate
Office:
Glenmark
House,
B.
D.
Sawant
Marg,
Andheri
(East),
Mumbai
400099,
Maharashtra,
India
Tel:
+912189
234456/
+912189
234246
Website:
www.glenmarklifesciences.com
Contact
Person:
Rudalf
Corriea
(Company
Secretary
and
Compliance
Officer)
E-mail:
[email protected]
Corporate
Identity
Number:
U74900PN2011PLC139963
Glenmark Life Sciences IPO FAQs
What is Glenmark Life Sciences IPO?
When Glenmark Life Sciences IPO will open?
What is Glenmark Life Sciences IPO Investors Portion?
How to Apply the Glenmark Life Sciences IPO?
How to Apply the Glenmark Life Sciences IPO through Zerodha?
How to Apply the Glenmark Life Sciences IPO through Upstox?
What is Glenmark Life Sciences IPO Size?
What is Glenmark Life Sciences IPO Price Band?
What is Glenmark Life Sciences IPO Minimum and Maximum Lot Size?
What is Glenmark Life Sciences IPO Allotment Date?
What is Glenmark Life Sciences IPO Listing Date?
Note: The Glenmark Life Sciences IPO details added as it is officially announced. The IPO grey market premium (Glenmark Life Sciences IPO Premium) started. You can check our IPO grey market page for daily updates.)